{
    "clinical_study": {
        "@rank": "142966", 
        "acronym": "POST", 
        "arm_group": [
            {
                "arm_group_label": "Group 1", 
                "description": "The MIRENA intrauterine delivery system (initial release rate: 20 \u03bcg LNG /24 h)"
            }, 
            {
                "arm_group_label": "Group 2", 
                "description": "Copper IUDs with different shape and with or without drugs"
            }
        ], 
        "brief_summary": {
            "textblock": "To observe the bleeding patterns of post-abortion immediate insertion of IUS compared to\n      Cu-IUD over the first 6 months."
        }, 
        "brief_title": "Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Contraception", 
        "condition_browse": {
            "mesh_term": "Hemorrhage"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Reproductive women in good general health and requesting long-term contraception\n\n          -  Applied the Cu-IUD or LNG-IUS immediately after first trimester surgical abortion\n\n          -  History of regular cyclic menstrual periods\n\n          -  Written ICF was obtained\n\n        Exclusion Criteria:\n\n          -  Suspected septic abortion and incomplete abortion, as well as missed abortion\n\n          -  The contraindications and warnings of the respective Summary of Product\n             Characteristics of Mirena or prescribing information of Cu-IUDs must be followed"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All subjects should go through the surgical abortion should meet both inclusion and\n        exclusion criteria. And they are willing to sign an informed consent. And all recruitment\n        should be conducted after the decision of treatment."
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01958684", 
            "org_study_id": "16954", 
            "secondary_id": "MA1310CN"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group 1", 
                "description": "LNG-IUS once inserted will be effective for 5 years.", 
                "intervention_name": "Levonorgestrel IUS (Mirena, BAY86-5028)", 
                "intervention_type": "Drug", 
                "other_name": "Mirena Group"
            }, 
            {
                "arm_group_label": "Group 2", 
                "description": "Copper-IUD once inserted will be effective for more than 10 years.", 
                "intervention_name": "Copper-IUD", 
                "intervention_type": "Device", 
                "other_name": "Cu-IUD Group"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Copper", 
                "Levonorgestrel"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Bleeding pattern", 
            "LNG-IUS", 
            "Cu-IUD", 
            "postabortion"
        ], 
        "lastchanged_date": "May 16, 2014", 
        "link": [
            {
                "description": "Click here and search for drug information provided by the FDA.", 
                "url": "http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm"
            }, 
            {
                "description": "Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.", 
                "url": "http://www.fda.gov/medwatch/safety.htm"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Many Locations", 
                    "country": "China"
                }
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Non-interventional Study to Observe the Bleeding Pattern of LNG-IUS Inserted Immediately After Surgical Abortion Compared With Copper IUD", 
        "overall_contact": {
            "email": "clinical-trials-contact@bayerhealthcare.com", 
            "last_name": "Bayer Clinical Trials Contact"
        }, 
        "overall_official": {
            "affiliation": "Bayer", 
            "last_name": "Bayer Study Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: None", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The 90-day reference period is recommended by the WHO. Day 1 is defined as the insertion day.", 
            "measure": "The number of bleeding/spotting days assessed over the second 90-day reference period after induced abortion", 
            "safety_issue": "No", 
            "time_frame": "Months 4 to 6"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01958684"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "It will be captured by patient dairy and measured by subjective scale as below.\nNo bleeding\nLight bleeding\nNormal bleeding\nHeavy bleeding\nVery heavy bleeding", 
                "measure": "Menstrual bleeding intensity", 
                "safety_issue": "No", 
                "time_frame": "up to 6 months"
            }, 
            {
                "measure": "Abortion related bleeding days", 
                "safety_issue": "No", 
                "time_frame": "up to 1 month"
            }, 
            {
                "description": "This data will be calculated by days", 
                "measure": "Time to the first menstrual bleeding following abortion", 
                "safety_issue": "No", 
                "time_frame": "up to 2 months"
            }, 
            {
                "measure": "Participants continuation rates of  Mirena and Cu-IUD", 
                "safety_issue": "No", 
                "time_frame": "up to 6 months"
            }, 
            {
                "description": "It will be calculated by percentage", 
                "measure": "Reasons for discontinuation of  Mirena and Cu-IUD", 
                "safety_issue": "No", 
                "time_frame": "Up to 6 months"
            }, 
            {
                "description": "It will be captured by satisfaction scale as below.\nVery satisfied\nRather satisfied\nneither satisfied nor dissatisfied\nRather unsatisfied\nVery unsatisfied", 
                "measure": "Participants satisfaction rates of  Mirena and Cu-IUD", 
                "safety_issue": "No", 
                "time_frame": "Up to 6 months"
            }, 
            {
                "description": "Adverse events  included: Pelvic inflammatory disease, Expulsion and Others.)", 
                "measure": "Percentage of participants with adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 6 months"
            }
        ], 
        "source": "Bayer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bayer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}